Ixtlan Bioscience

24/11/2022

https://microdose.buzz/news/new-study-show-psychedelics-lower-barriers-to-higher-brain-states/

A recent study conducted by Cornell University has shown that psychedelics might lower the energy threshold brain networks require in order to shift to different configurations. How is this possible?

09/11/2022

https://hightimes.com/psychedelics/north-americas-first-take-home-psilocybin-trial-approved-in-canada/

Participants will be allowed to take home psilocybin in a study examining its effects on depression and post-traumatic stress disorder.

21/10/2022

And while not everyone has a positive experience, many users report feeling a deep sense of connection to the universe.

https://www.pbs.org/wgbh/nova/article/psychedelic-brain-effects-claustrum/

The claustrum seems to act as a switchboard, telling different parts of the brain when to turn on and off. But what happens when the switchboard operator steps away?

13/10/2022

According to the study, the mice showed signs of decreased depression without showing any physical indicators that they were high on acid.

https://hightimes.com/psychedelics/decaf-acid-new-lsd-derivatives-may-offer-mental-health-benefits-without-the-trip/

A study on newly-derived L*D derivatives claims these compounds may be able to treat depression without the additional 12-hour long magic carpet ride.

09/10/2022

"It shouldn't be scary, it should be a guide," Chris said.

https://www.insider.com/brothers-are-exploring-how-mushrooms-can-help-with-alzheimers-2022-10

After their father and grandfather died of Alzheimer's, they founded a company to better understand how regular and psychedelic mushrooms can help.

30/09/2022

Psychedelic medicines coupled with psychotherapy might “change the way we experience pain”.

https://www.nature.com/articles/d41586-022-02878-3

Drugs best known for their hallucinogenic properties, such as psilocybin, could help people beat the agony of migraines and other painful maladies.

25/09/2022

Psychedelics such as psilocybin “truly have the potential to revolutionize how we treat several neuropsychiatric diseases, including headaches,”

https://microdose.buzz/news/science-feature-psilocybin-for-headaches/

With mounting evidence to support the use of psychedelics in treating serious disorders like PTSD, depression, and anxiety — the sector is now beginning to focus on more highly specialized conditions like headaches.

19/09/2022

After four years of optimistic funding fueled by strong research from top-tier universities, the novelty surrounding startups in the psychedelics market has died down and funding isn’t as generous as it used to be.

https://news.crunchbase.com/health-wellness-biotech/psychedelics-market-startup-funding/

After four years of optimistic funding fueled by strong research from top-tier universities, the novelty surrounding startups in the psychedelics market has died down and funding isn’t as generous as it used to be.

17/09/2022

https://www.corvallisadvocate.com/2022/the-money-in-magic-mushrooms/

Billions could be made from the blooming psilocybin industry. Many states and investors all over the country have their eyes on how Oregon is trailblazing this new territory. In 2020, Measure 109 passed allowing psilocybin – the magic in magic mushrooms – to be used therapeutically or for person...

10/09/2022

In recent years, microdosing—aka taking tiny amounts of drugs like L*D and psilocybin—has gone from being the talk of the psychedelic village to being perceived as a super cool secret weapon

https://www.vice.com/amp/en/article/4axn7d/microdosing-drugs-experience-effects-lsd-pscyhedelics

“It’s like a heightened version of being sober.”

08/09/2022

Some studies have suggested that the serotonin system, including serotonin transporters and receptors, differs between autistic and non-autistic individuals.

https://www.technologynetworks.com/neuroscience/blog/psilocybin-study-to-investigate-the-serotonin-system-in-autism-365462

04/09/2022

She looks healthy for 47. She’s vibrant, friendly, and talkative. She doesn’t seem to have a problem sharing her feelings about things and exudes an energy that welcomes you into her world while

https://www.thedailybeast.com/meet-the-woman-using-psilocybin-mushrooms-for-end-of-life-anxiety-with-field-trips?ref=home

Both psychedelic drug use and talking about death are big stigmas in the western world—but one dying woman wants to change that.

02/09/2022

We’re firmly in the midst of a psychedelic renaissance, with substances long regarded simply as recreational drugs—such as psilocybin, L*D, and M**A

https://www.wired.com/story/psychedelic-hype-bubble/

A new paper argues that excitement has veered into misinformation—and scientists should be the ones to set things straight.

28/08/2022

https://www.psychologytoday.com/us/blog/the-promise-psychedelics/202208/microdosing-psychedelics-hope-or-hype

Is this simply a placebo effect?

26/08/2022

https://www.inverse.com/mind-body/near-death-experiences-psychedelic-trips-changes-in-mindset

In a new study, researchers sought to understand changes in a person's attitude following near-death incidents and doses of psilocybin.

25/08/2022

And now here we are, four years after Michael Pollan’s book kicked off the movement, and the Psychedelic Renaissance is hitting a serious rough patch.

https://psychedelicspotlight.com/how-long-can-the-psychedelic-renaissance-last/

The Psychedelic Renaissance is in full effect, but how long can the party last? We look to previous psychedelic movements to find the answer

22/08/2022

https://www.fiercebiotech.com/biotech/psychedelics-are-getting-closer-to-approval-but-market-may-not-be-ready

This story is part two in a two-part series looking at the psychedelics drug development landscape. | Investor interest is pushing psychedelics-based therapy mainstream and it’s now time to figure out the tricky regulatory issues that have held these therapies back, as the leading developer moves ...

20/08/2022

A team at the University of North Carolina at Chapel Hill has now reported that natural variations in a serotonin receptor could affect how some psychedelic compounds interact with people’s cells,

https://cen.acs.org/pharmaceuticals/neuroscience/Response-psychedelic-drugs-depend-small/100/web/2022/08

In vitro study reports that natural mutations that change a serotonin receptor’s structure may impacting drugs’ potency